Holen Sie sich die Stockscreener-App
170.93
5.16%
8.38
Vorhandelsmarkt:
172.75
1.82
+1.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina Inc. stock (US4523271090): shares edge higher on Nasdaq amid focus on sequencing demand and - AD HOC NEWS
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina jumps as bullish analyst note extends optimism around clinical sequencing momentum - Quiver Quantitative
ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge? - TradingView
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina, Inc. Hits New 52-Week High of $165.93, Up 54% - Markets Mojo
Illumina, Inc. Hits New 52-Week High at USD 165.37 - Markets Mojo
Illumina, Inc. Hits New 52-Week High of $158.78, Up 48.7% - Markets Mojo
[144] ILLUMINA, INC. SEC Filing - Stock Titan
Frances Arnold reports proposed sale of 5,000 shares | ILMN SEC FilingForm 144 - Stock Titan
IDT partners with Illumina on oncology research workflow - Investing.com UK
Insider Sell: Scott Davies Sells Shares of Illumina Inc (ILMN) - GuruFocus
Why (ILMN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Illumina director Keith Meister sells $107 million in shares - Investing.com
Corvex funds tied to Illumina (ILMN) log 669,596-share stock sale - Stock Titan
Guggenheim raises Illumina stock price target on clinical market strength - Investing.com UK
Illumina VP, chief accounting officer sells $305,150 in ILMN stock - Investing.com
Illumina (ILMN) legal chief sells 615 shares in open market trade - Stock Titan
Illumina Inc. stock (US4523271090): New oncology research workflows and MRD solution highlight innov - AD HOC NEWS
Illumina (ILMN) chief accounting officer sells 2,000 company shares in open market - Stock Titan
Hunting for hidden clues in the human genome’s “dark regions” - Illumina
Integrated DNA Technologies (DHR) Partners with Illumina for Enh - GuruFocus
IDT partners with Illumina on oncology research workflow By Investing.com - Investing.com Canada
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights - Eagle-Tribune
Guggenheim Maintains Illumina(ILMN.US) With Buy Rating, Raises Target Price to $180 - Moomoo
Guggenheim raises Illumina stock price target on clinical market strength By Investing.com - Investing.com Australia
Illumina, Inc. (ILMN) Stock Analysis: Understanding the Growth Potential Amidst a Robust Market Cap - DirectorsTalk Interviews
Illumina Inc. stock (US4523271090): shares track Nasdaq ahead of next catalysts - AD HOC NEWS
Here's why Illumina (ILMN) is a strong momentum stock - MSN
Illumina Oncology Launches Put Product Depth Against Rapid Share Price Gains - Yahoo Finance Singapore
Illumina Inc. stock (US4523271090): insider share sale and new MRD kit draw investor focus - AD HOC NEWS
Why Illumina (ILMN) is a top momentum stock for the long term - MSN
Illumina Ducks DNA Sequence Rival's Antitrust Suit, For Now - Law360
Corvex Management LP sells multiple ILMN blocks (ILMN) in May 2026 - Stock Titan
lllumina Beats Rival’s DNA-Sequencing Tool Monopolization Claims - Bloomberg Law News
Illumina, Inc. Hits Day High with Strong 5.68% Intraday Surge - Markets Mojo
Illumina (NASDAQ: ILMN) director sold 1,500 shares under 10b5-1 plan - Stock Titan
Illumina (ILMN) director Keith Meister updates 3.5M indirect share position - Stock Titan
Illumina launches new sequencing tech for molecular residual disease research - MSN
Illumina Inc. stock (US4523271090): shares near 12-month high after new automation launch - AD HOC NEWS
Illumina and SPT Labtech on fire with new collaboration - Business Weekly
Assessing Illumina (ILMN) Valuation After Its New MRD Research Solution Expands Oncology Offering - Sahm
Illumina Inc stock (US4523271090): New MRD research launch and fresh 52-week high draw focus to valu - AD HOC NEWS
Illumina (ILMN) Form 144: Brokered notice to sell 1,500 shares - Stock Titan
Illumina stock hits 52-week high at 155.6 USD By Investing.com - Investing.com Nigeria
Frances Arnold proposes sale of 5,000 ILMN shares (ILMN) - Stock Titan
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research - Illumina
Illumina's new fireflyGO robot targets faster cancer lab workflows - Stock Titan
Illumina, Inc. Introduces Distributed Whole-Genome Sequencing Solution For Highly Sensitive MRD Research - marketscreener.com
Illumina stock hits 52-week high at 155.6 USD - Investing.com
Illumina launches whole-genome sequencing kit for cancer research By Investing.com - Investing.com Australia
Illumina launches whole-genome sequencing kit for cancer research - Investing.com
Illumina cancer research workflow spots tiny traces of disease in 5 days - Stock Titan
Illumina introduces the first distributed whole-genome sequencin - GuruFocus
Illumina Shareholders Back Board, Auditor and Executive Pay - The Globe and Mail
Is Illumina Inc (ILMN) Overvalued After 3.4% Rally? GF Value Say - GuruFocus
Illumina, Inc. Files Form 8-K Announcing Annual Meeting Results and Company Information (May 2026) - Minichart
Illumina (ILMN) shareholders back board slate, auditor and pay at 2026 meeting - Stock Titan
Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy? - Yahoo Finance
Action challenging Commission’s jurisdiction over Grail’s acquisition of Illumina, published in OJ - EU Law Live
Illumina Multiomics Summit India highlights potential of integrated omics - BioSpectrum India
0.06%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):